Article Information
History
- March 27, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Mohsen Basiria,
- Mohammad E. Ghaffarib,
- Jiapeng Ruana,
- Vagishwari Murugesanc,
- Nathaniel Kleytmana,
- Glenn Belinskya,
- Amir Akhavand,
- Andrew Lischuke,
- Lilu Guof,
- Katherine Klingerf and
- Pramod K. Mistrya,*
- aDepartment of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA
- bDepartment of ENT, Head and Neck Surgery, Guilan University of Medical Science, Rasht, Iran
- cDepartment of Rheumatology, University of Toronto, Toronto, Ottawa, CA
- dDepartment of Computer and Information Science, UMass Dartmouth, North Dartmouth, MA, USA
- eDepartment of Radiology & Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA
- fTranslational Sciences, Sanofi, Framingham, MA,USA
- ↵*Corresponding Author:
Pramod K. Mistry, MD, PhD, Department of Internal Medicine, Yale School of Medicine, The Anlyan Center (TAC), Suite 241, One Gilbert Street, New Haven, CT 06519 Telephone: 203-785-3412 | Fax: 203-785-7273 | Email: Pramod.mistry{at}yale.edu
Posted March 27, 2023.
Osteonecrosis in Gaucher Disease in the era of multiple therapies: biomarker set for risk stratification from a tertiary referral center
